BR112023017802A2 - Marcadores de interação cromossômica - Google Patents

Marcadores de interação cromossômica

Info

Publication number
BR112023017802A2
BR112023017802A2 BR112023017802A BR112023017802A BR112023017802A2 BR 112023017802 A2 BR112023017802 A2 BR 112023017802A2 BR 112023017802 A BR112023017802 A BR 112023017802A BR 112023017802 A BR112023017802 A BR 112023017802A BR 112023017802 A2 BR112023017802 A2 BR 112023017802A2
Authority
BR
Brazil
Prior art keywords
interaction markers
chromosome interaction
markers
chromosome
chromosomal
Prior art date
Application number
BR112023017802A
Other languages
English (en)
Portuguese (pt)
Inventor
Alexandre Akoulitchev
Selvam Ramadass Aroul
Ewan Hunter
Original Assignee
Oxford BioDynamics PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford BioDynamics PLC filed Critical Oxford BioDynamics PLC
Publication of BR112023017802A2 publication Critical patent/BR112023017802A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/686—Polymerase chain reaction [PCR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2531/00—Reactions of nucleic acids characterised by
    • C12Q2531/10—Reactions of nucleic acids characterised by the purpose being amplify/increase the copy number of target nucleic acid
    • C12Q2531/113—PCR
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BR112023017802A 2021-03-04 2022-03-03 Marcadores de interação cromossômica BR112023017802A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163156659P 2021-03-04 2021-03-04
US202163282284P 2021-11-23 2021-11-23
PCT/GB2022/050561 WO2022185062A1 (en) 2021-03-04 2022-03-03 Chromosome interaction markers

Publications (1)

Publication Number Publication Date
BR112023017802A2 true BR112023017802A2 (pt) 2023-12-12

Family

ID=80735500

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112023017802A BR112023017802A2 (pt) 2021-03-04 2022-03-03 Marcadores de interação cromossômica

Country Status (15)

Country Link
US (1) US20240229135A9 (cg-RX-API-DMAC7.html)
EP (1) EP4301874B1 (cg-RX-API-DMAC7.html)
JP (1) JP2024511292A (cg-RX-API-DMAC7.html)
KR (1) KR20240006020A (cg-RX-API-DMAC7.html)
AU (1) AU2022230780B2 (cg-RX-API-DMAC7.html)
BR (1) BR112023017802A2 (cg-RX-API-DMAC7.html)
CA (1) CA3209544A1 (cg-RX-API-DMAC7.html)
ES (1) ES3029416T3 (cg-RX-API-DMAC7.html)
GB (1) GB2618727B (cg-RX-API-DMAC7.html)
HU (1) HUE071359T2 (cg-RX-API-DMAC7.html)
IL (1) IL304883A (cg-RX-API-DMAC7.html)
PL (1) PL4301874T3 (cg-RX-API-DMAC7.html)
TW (1) TW202302862A (cg-RX-API-DMAC7.html)
WO (1) WO2022185062A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202309162B (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202412610D0 (en) * 2024-08-28 2024-10-09 Oxford BioDynamics PLC Screening method

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111511930B (zh) * 2017-11-03 2024-11-22 牛津生物动力有限责任公司 通过染色体相互作用遗传调节免疫响应
WO2020198676A1 (en) * 2019-03-28 2020-10-01 Bristol-Myers Squibb Company Methods of treating tumor
GB2626699B (en) * 2019-05-08 2024-11-20 Oxford BioDynamics PLC Chromosome Conformation Markers of Prostate Cancer and Lymphoma
WO2021228888A1 (en) * 2020-05-12 2021-11-18 Asylia Diagnostics Biomarkers for hyperprogressive disease and therapy response after immunotherapy

Also Published As

Publication number Publication date
JP2024511292A (ja) 2024-03-13
US20240229135A9 (en) 2024-07-11
TW202302862A (zh) 2023-01-16
AU2022230780A1 (en) 2023-10-12
EP4301874C0 (en) 2025-04-23
HUE071359T2 (hu) 2025-08-28
ES3029416T3 (en) 2025-06-24
EP4301874B1 (en) 2025-04-23
GB202313067D0 (en) 2023-10-11
WO2022185062A1 (en) 2022-09-09
AU2022230780B2 (en) 2024-05-23
ZA202309162B (en) 2025-03-26
GB2618727A (en) 2023-11-15
US20240132959A1 (en) 2024-04-25
PL4301874T3 (pl) 2025-06-23
GB2618727B (en) 2024-07-17
KR20240006020A (ko) 2024-01-12
CA3209544A1 (en) 2022-09-09
EP4301874A1 (en) 2024-01-10
IL304883A (en) 2023-10-01

Similar Documents

Publication Publication Date Title
MX2022014166A (es) Metodos para tratar el mieloma multiple.
BR112022002604A2 (pt) Processo de produção de moduladores de cftr
CL2021001690S1 (es) Estuche para audífonos.
BR112019018124A2 (pt) composições e métodos para imunooncologia
CL2020001637A1 (es) Anticuerpos para lilrb2
MX384823B (es) Agentes de alta afinidad dirigidos a antígeno de membrana específico de próstata para endoradioterapia de cáncer de próstata.
CL2019001252S1 (es) Herramienta de corte.
CL2021001175S1 (es) Estuche para audífonos.
MX420023B (es) Moléculas guía sintéticas, composiciones y métodos relacionados con éstas.
CO2017010618A2 (es) Anticuerpos contra icos
CO2018013112A2 (es) Compuestos de carfilzomib pegilados
UY40769A (es) “ANTICUERPOS AISLADOS BIESPECÍFICOS GPRC5D x CD3 Y COMPOSICIONES QUÍMICAS QUE LOS CONTIENEN”
EP4162044A4 (en) GUIDE RNA TEMPLATE MOLECULES
BR112015032718A2 (pt) composto de modificação de splicing do gene foxm1, uso do composto, formulação farmacêutica e métodos de triagem de compostos
CL2020002510A1 (es) Radiofármaco dirigido a antígeno de membrana específico de próstata (psma) para diagnosticar y tratar el cáncer de próstata
AU2017261442A1 (en) Detection of chromosome interaction relevant to breast cancer
BR112021024852A2 (pt) Métodos de cultura de célula e composições para produção de anticorpo
MX374630B (es) Metodo para el acabado de engranajes templados.
BR112016026009A2 (pt) Processo para fazer polímeros à base de etileno, usando iniciadores de hidrocarbonetos
BR112017000417A2 (pt) processo para preparação de fenil alcanos substituídos
CL2023000942A1 (es) Síntesis de un inhibidor de calicreína plasmática a escala de proceso .
PT3806992T (pt) Processo e instalação para a produção de metanol
MY200184A (en) Biomarker
ZA202309162B (en) Chromosome interaction markers
MY203765A (en) Chromosome conformation markers of prostate cancer and lymphoma